2021 - 2024 Missense rare variant analysis of APOE: Exploring the link between lipid metabolism and Alzheimer's disease
2019 - 2022 Microglia-astrocyte crosstalk in leukoencephalopathies
2016 - 2019 ミクログリアの異常がなぜ白質変性をきたすのか
2014 - 2017 Globular glial tauopathy: investigation of the pathological features
2014 - 2017 Amyotrophic Lateral Sclerosis and TDP-43: Elucidation of molecular neuropathology in terms of spread from its beginning
2014 - 2016 Heterogeneity of TDP-43 pathology and clinicopathologic correlations in sporadic amyotrophic lateral sclerosis
2013 - 2016 多系統萎縮症における認知機能障害の責任病巣:臨床病理学的検討
Show all
Papers (80):
Takayuki Sakai, Aya Ogata, Hiroshi Ikenuma, Takashi Yamada, Saori Hattori, Junichiro Abe, Shinichi Imamura, Masanori Ichise, Mari Tada, Akiyoshi Kakita, et al. A novel PET probe to selectively image heat shock protein 90α/β isoforms in the brain. EJNMMI Radiopharmacy and Chemistry. 2024. 9. 1
Jotaro On, Manabu Natsumeda, Haruhiko Takahashi, Akihide Koyama, Satoshi Shibuma, Nao Shibata, Jun Watanabe, Shoji Saito, Yu Kanemaru, Yoshihiro Tsukamoto, et al. Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors. Journal of neuro-oncology. 2024. 166. 2. 273-282
Ikuko Aiba, Yuichi Hayashi, Takayoshi Shimohata, Mari Yoshida, Yuko Saito, Koichi Wakabayashi, Takashi Komori, Masato Hasegawa, Takeshi Ikeuchi, Aya M Tokumaru, et al. Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome. Brain Communications. 2023. 5. 6
Aya Ogata, Takashi Yamada, Saori Hattori, Hiroshi Ikenuma, Junichiro Abe, Mari Tada, Masanori Ichise, Masaaki Suzuki, Kengo Ito, Takashi Kato, et al. Development of a novel PET ligand, [11C]GO289 targeting CK2 expressed in the brain. Bioorganic & medicinal chemistry letters. 2023. 90. 129327-129327
Haruhiko Takahashi, Manabu Natsumeda, Jotaro On, Jun Watanabe, Mari Tada, Hiroshi Shimizu, Yoshihiro Tsukamoto, Masayasu Okada, Makoto Oishi, Jun Takizawa, et al. Administration of glucocorticoids prior to liquid biopsy dramatically reduces the detection rate of <i>MYD88 L265P</i> mutation in cerebrospinal fluid of primary CNS lymphoma patients. Leukemia & Lymphoma. 2023. 64. 6. 1219-1222